skip to Main Content

A multidisciplinary approach to beating liver disease

In 2021, we will be bringing the members of our community together again in person, around the same table, to explore how to tackle liver disease using a multidisciplinary approach. Attendees will hear the latest in epidemiological and real-world data on liver disease and gain a deeper understanding of the underlying mechanisms. Leading clinicians and researchers in the field will talk about daily interactions with patients, to help or even reverse liver disease, and updates on treatment options.

We will also offer flagship features, such as the basic science programme and post-graduate course.

Don’t miss the compelling key parts of our flagship event:

  • Abstract sessions & late-breakers
  • Meet the experts
  • Young Investigators seminars
  • Basic science seminar
  • Postgraduate course
  • Awards ceremony
  • Special content for nurses and allied health professionals
  • Poster tours
  • Industry satellite symposia

Here is a sneak preview for the Scientific Programme Overview

One-day courses

1. Postgraduate course: Lifestyle and the liver
2. Basic science seminar: Artificial intelligence and omics data in hepatology

State of the Art lectures

1. Immunotherapy in HCC
2. Immunometabolism for hepatologists?
3. Steps towards cirrhosis – and back?

General hepatology

Key topics addressed

1. Advances in basic science and regenerative medicine
2. Application of computer science in hepatology: the role of big data processing for integrating omics data, and artificial intelligence for improving disease risk stratification and image interpretation
3. Update on immunological liver diseases and liver transplantation
4. Update on the most significant advances relevant to all hepatologists over the past year

Metabolic, alcohol and toxicity

Key topics addressed:

1. Role of lifestyle in the pathogenesis of liver disease – obesity and excess alcohol as main aetiological factors
2. New screening and case-finding strategies for liver disease in the population and novel biomarkers
3. Emerging mechanisms of disease, including the role of the gut-liver axis and inflammatory pathways
4. Advancements in the development of new treatments and therapeutic approaches for non-alcoholic fatty liver disease

Cholestasis and autoimmune

Key topics addressed

1. Clinical considerations from itch and fatigue, to bone and skin disorders in cholestasis
2. A pros and cons session will also address whether or not to use Fxr agonists in cholangiopathies
3. A Grand Rounds session will tackle the discussion on managing patients with sclerosing cholangitis
4. A deeper understanding of the genetic and cellular mechanisms leading to cholestasis is needed; and will be the focus of both a Symposium and a Meet the Experts sessions

Cirrhosis and complications

Key topics addressed:

1. Liver vessels changes as drivers of liver disease progression
2. Management of ascites acute kidney and its complications
3. Management of oesophageal varices in 2021
4. New challenges in the management of vascular liver diseases

Viral hepatitis

Key topics addressed:

1. The pipeline to cure chronic hepatitis B
2. The road towards global HCV elimination
3. New treatment options for chronic hepatitis D are on the horizon
4. Understanding the pathogenesis of hepatitis E virus infection and developing concepts to cure chronic hepatitis E

Liver tumours

Key topics addressed:

1. Knowledge in the liver carcinogenesis mechanisms is growing
2. Radiology and pathology tools for liver cancer diagnosis
3. Management of special populations
4. Immunotherapy in liver cancer

Back To Top